MedPath

Dexcel Pharma Technologies Ltd.

Dexcel Pharma Technologies Ltd. logo
🇮🇱Israel
Ownership
Subsidiary
Established
1968-01-01
Employees
501
Market Cap
-
Website
http://www.dexcel.com

Clinical Trials

7

Active:2
Completed:5

Trial Phases

3 Phases

Phase 1:2
Phase 2:3
Phase 3:2

Drug Approvals

1

FDA:1

Drug Approvals

Donepezil Hydrochloride

Approval Date
Feb 14, 2017
FDA

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 2
3 (42.9%)
Phase 1
2 (28.6%)
Phase 3
2 (28.6%)

The Efficacy and Safety of Chlorhexidine Gluconate Chip (PerioChip®) in Therapy of Peri-implantitis

Phase 3
Completed
Conditions
Peri-Implantitis
Interventions
First Posted Date
2014-03-06
Last Posted Date
2022-09-13
Lead Sponsor
Dexcel Pharma Technologies Ltd.
Target Recruit Count
290
Registration Number
NCT02080403
Locations
🇺🇸

University of Maryland, School of Dentistry, Department of Periodontics, Baltimore, Maryland, United States

🇺🇸

The Harvard School of Dental Medicine, Boston, Massachusetts, United States

🇺🇸

Tufts University, School of Dental Medicine, Department of Oral Medicine, Boston, Massachusetts, United States

and more 7 locations

The Efficacy and Safety of 2.5 mg Chlorhexidine Gluconate Chip (PerioChip®) in Frequent Treatment Versus Routine Treatment in Therapy of Adult Chronic Periodontitis

Phase 3
Completed
Conditions
Generalized Adult Periodontitis
Interventions
First Posted Date
2010-11-30
Last Posted Date
2013-01-17
Lead Sponsor
Dexcel Pharma Technologies Ltd.
Registration Number
NCT01249846
Locations
🇮🇱

Department of Periodontology, School of Graduate Dentistry, Rambam Health Care Center, Haifa, Israel

The Efficacy and Safety of Chlorhexidine Gluconate Chip (Periochip®) in Therapy of Symptoms in Patients With Peri-implantitis

Phase 2
Completed
Conditions
Peri-implantitis
Interventions
Drug: Placebo chip
First Posted Date
2010-03-03
Last Posted Date
2021-06-15
Lead Sponsor
Dexcel Pharma Technologies Ltd.
Target Recruit Count
60
Registration Number
NCT01079663
Locations
🇮🇱

Department of Periodontology, School of Graduate Dentistry, Rambam Health Care Center, Haifa, Israel

🇮🇱

The Oral & Maxillofacial Surgery Unit of the Tel Aviv Medical Center, Tel Aviv, Israel

The Efficacy and Safety of Flurbiprofen Chip Versus Chlorhexidine Chip (Periochip®) in Therapy of Adult Chronic Periodontitis

Phase 2
Completed
Conditions
Periodontitis
Interventions
First Posted Date
2009-12-29
Last Posted Date
2010-07-07
Lead Sponsor
Dexcel Pharma Technologies Ltd.
Registration Number
NCT01040286
Locations
🇮🇱

Department of Periodontology, School of Graduate Dentistry, Rambam Health Care Center, Haifa, Israel

The Efficacy and Safety of PerioChip Plus (Flurbiprofen/Chlorhexidine) Formulation in the Therapy of Adult Periodontitis

First Posted Date
2007-01-23
Last Posted Date
2011-06-14
Lead Sponsor
Dexcel Pharma Technologies Ltd.
Target Recruit Count
80
Registration Number
NCT00425451
Locations
🇮🇱

Hadassah Medical Organization, Jerusalem, Israel

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.